On May 14, 2026, Ocugen, Inc. announced the issuance of an additional $15 million in 6.75% Convertible Senior Notes due 2034, following a previous offering that raised $115 million on May 7, 2026. This could lead to the issuance of up to 8,108,108 shares of common stock upon conversion, depending on terms outlined in the notes.